Delivery Order SPE2DB22D2007-SPE2DB24FJ4BD

Award Date 7/10/24
Potential Completion Date 7/31/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The single-award, indefinite delivery contract (IDC) has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to provide a...
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a $5,624.62 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide TASIGNA 150 MG CAPSULE 28S, with a completion date of February 15, 2024. This award is part of a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as Amerisourcebergen's primary contract to deliver pharmaceuticals and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $11,249.24 and a period of performance through July 3, 2024. It is a Firm Fixed Price contract type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This...
This federal contract award, valued at $12,015.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567751543 ! TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of April 21, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical program. The contract, valued at $5,624.62, is a Firm Fixed Price Delivery Order with a completion date of November 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,276.04 Firm Fixed Price Delivery Order contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a specialty medication. The contract has a period of performance through March 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,819.01, is a firm fixed price delivery order for the supply of TASIGNA 200 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $6,007.90 and a period of performance through April 22, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $5,819.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of Tasigna 150 mg capsule 28s, a pharmaceutical product. The award, valued at $11,249.24, was issued by the Defense Logistics Agency (DLA) on August 18, 2023, with a completion date of September 11, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ4BD
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $5,624.62 and a term ending on July 31, 2024. It is a firm fixed-price delivery order contract, without any set-aside designation.

Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical and medical products to DLA facilities supporting the DoD worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/9/24, 9:25 AM